Tag: kite pharma

November 2, 2016

Kite Pharma to Report Third Quarter 2016 Financial Results on November 9, 2016

Kite Pharma today announced that it will report third quarter 2016 financial results on Wednesday, November 9, 2016, prior to...
October 11, 2016
September 13, 2016

Yesterday Was a Big Day for Biotech

Biotech has been beset in recent months: negative media coverage, the American election, and some disappointing clinical trial results contributed...
July 10, 2016

Top Trends in the Cancer Immunotherapy Sector

Loncar Investments founder, independent biotech investor and analyst Brad Loncar comments on the biggest trends in the cancer immunotherapy space.
July 4, 2016

Loncar Cancer Immunotherapy Index Tracks Dynamic Biotechnology Market

An exclusive interview with Loncar Investments founder, independent biotech investor and analyst Brad Loncar.
June 13, 2016

Alpine Immune Sciences Announces $48 Million Series A Financing to Support Discovery and Development of the Next Generation of Immunotherapies

SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc., (AIS), a privately held biotechnology company developing a next-generation immune system modulation platform, today announced...
July 29, 2015

NantKwest's Record-breaking $2.6-billion IPO Valuation

NantKwest hit the stock market on Tuesday with an initial public offering hat values the company at $2.6 billion.